Login or sign up
For business

Engene inc

4.0Β· 11 reviews
Average ratingGreat
4.0/ 5

Based on 11 reviews

536%
427%
336%
20%
10%
Ask AI

Questions about Engene inc

Based on 11 reviews, listing data and website checks Β· updated 5 days ago

What is Engene inc?

Engene inc is a biotechnology company located at 2386 East Mall # 100 in Arbutus Ridge, British Columbia, Canada. They specialize in non-viral gene therapies placed precisely where they're needed, with a focus on treatments like detalimogene for bladder cancer. The company has been mentioned in multiple news articles regarding their clinical trials and regulatory milestones.

What do reviewers praise about Engene inc?

The company's team is described as highly skilled, knowledgeable, and efficient by multiple reviewers. They are praised for delivering exceptional results, being prompt, and providing excellent support to their clients. Reviewers consistently highlight the professionalism and competence of their staff.

How recent are the reviews and what is the rating?

As of the latest data, Engene inc has a Trustburn rating of 4 out of 5 stars from 11 reviews. The most recent review was posted on November 19, 2023, and the reviews span from January 2023 to November 2023.

What key executive changes have occurred at Engene inc?

The company recently appointed Erik T. Goluboff, MD, MBA as Chief Medical Officer and Jason Duncan as Chief Legal and Administrative Officer. These appointments were made in anticipation of upcoming regulatory and commercial milestones for their gene therapy products.

What makes Engene inc different from competitors?

According to their own statements, Engene inc aims to deliver on its promises with a dedicated, skilled, and efficient team. They strive to provide top-notch solutions and exceed client expectations in their biotechnology projects.

How long has Engene inc been in operation?

The company has a history of delivering work on time and maintaining high standards of professionalism. They have successfully completed multiple projects for clients, earning a strong reputation for reliability and expertise.

Where is Engene inc located?

Engene inc is located at 2386 East Mall # 100, Arbutus Ridge, British Columbia.

How can I contact Engene inc?

You can reach Engene inc by phone at 6042214362 or by e-mail at info@engene.com.

What is the official website of Engene inc?

The official website of Engene inc is engeneinc.com.

Is Engene inc on social media?

Engene inc has official profiles on Linkedin.

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website β€” a simple way to convert your visitors into customers.

Get the widget for your site →

About Engene inc

Non-viral gene therapies placed precisely where they’re needed.

Engene Inc: Revolutionizing Gene Therapy with Non-Viral Solutions

Gene therapy has been a promising field for decades, but it has faced significant challenges in delivering therapeutic genes to the right cells without causing adverse effects. Viral vectors have been the go-to method for gene delivery, but they come with risks such as immune reactions and insertional mutagenesis. Engene Inc is a biotech company that aims to overcome these limitations by developing non-viral gene therapies that can be precisely targeted to specific tissues and cells.

Engene's technology platform is based on proprietary lipid nanoparticles (LNPs) that can encapsulate DNA or RNA molecules and deliver them into cells without triggering an immune response. These LNPs are designed to mimic the natural structure of cell membranes, which allows them to fuse with target cells and release their cargo inside. This approach offers several advantages over viral vectors, including lower toxicity, higher specificity, and easier manufacturing.

One of Engene's flagship products is its LNP-based CRISPR/Cas9 system for genome editing. This technology enables precise modifications of DNA sequences in living cells by using a guide RNA molecule that directs the Cas9 enzyme to cut the target site. The modified DNA can then be repaired or replaced with a new sequence using various mechanisms such as homology-directed repair (HDR) or non-homologous end joining (NHEJ). This approach has enormous potential for treating genetic diseases caused by mutations in specific genes.

Another area where Engene's technology could make a difference is cancer immunotherapy. By delivering therapeutic genes encoding immune-stimulating proteins directly into tumor cells or nearby tissues, Engene's LNPs could activate an anti-tumor immune response without affecting healthy tissues. This approach could complement existing immunotherapies such as checkpoint inhibitors or CAR-T cell therapy and improve their efficacy.

Engene also offers custom LNP formulation services for academic researchers and biopharmaceutical companies who want to develop their own non-viral gene therapies. Engene's team of experts can optimize the LNPs' properties for specific applications, such as tissue targeting, stability, or release kinetics. This service could accelerate the development of new gene therapies and expand the range of diseases that can be treated with this approach.

Engene's technology has already attracted attention from investors and collaborators. In 2020, Engene raised $50 million in a Series A funding round led by Morningside Ventures and 6 Dimensions Capital. The company also signed a research collaboration agreement with Takeda Pharmaceutical Company to develop non-viral gene therapies for rare genetic diseases.

In summary, Engene Inc is a biotech company that develops non-viral gene therapies based on proprietary lipid nanoparticles. Its technology platform offers several advantages over viral vectors, including lower toxicity, higher specificity, and easier manufacturing. Engene's products include an LNP-based CRISPR/Cas9 system for genome editing and potential cancer immunotherapies. The company also offers custom LNP formulation services for academic researchers and biopharmaceutical companies. With its innovative approach to gene therapy delivery, Engene has the potential to transform the field and improve patients' lives worldwide.

Address
2386 East Mall # 100
Categories
Biotechnology